Heart Defects, Congenital
99
8
11
56
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Research Maturity
56 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.1%
7 terminated out of 99 trials
88.9%
+2.4% vs benchmark
13%
13 trials in Phase 3/4
18%
10 of 56 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 56 completed trials
Clinical Trials (99)
CHAMP App Cardiac Study and Repository
Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions
Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction
Long-term Effects of Family WISH Program for Adolescents With Congenital Heart Disease
The Effects of Different Prone Positioning Angles on Cardiopulmonary Function in Children After Congenital Heart Disease Surgery: A Randomized Controlled Trial
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System
COMPASSION XT PAS - Post-approval Study of the SAPIEN XT THV in Patients With Pulmonary Valve Dysfunction
Tuning in to Kids: An Online, Group Program Tailored for Parents of Children With Congenital Heart Disease
Genetics of Ventriculo-arterial Discordance
Advancing the Science of Pediatric Interstage Home Monitoring
Mind the Heart - Mental Health in Children and Adolescents With Congenital Heart Defects
HeartGPS: A Study Exploring the Effects of a Psychological Intervention for Parents and Their Babies After Prenatal Cardiac Diagnosis
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
High-Flow Nasal Cannula vs. NIV After Extubation in Children Undergoing Heart Surgery
Development and Improvement of Home Rehabilitation Scheme for Preschool Children With Congenital Heart Disease After Operation
Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered Vascular Grafts
Global Utilization And Registry Database for Improved heArt preservatioN
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Congenital Heart Disease Physical Activity Lifestyle Study V.2